Welcome to our dedicated page for Adtalem Global Ed SEC filings (Ticker: ATGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Adtalem Global Education Inc. (NYSE: ATGE), a for-profit operator of colleges, universities, and professional schools with a strong emphasis on healthcare education. As a New York Stock Exchange–listed company, Adtalem files periodic and current reports that offer detailed information on its operations, financial condition, governance, and shareholder-related actions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q contain segment-level data for the Chamberlain, Walden, and Medical and Veterinary segments, along with discussions of enrollment, revenue, operating income, and risk factors. These filings help readers understand how institutions such as Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine contribute to Adtalem’s overall results.
Current reports on Form 8-K document specific material events. Recent 8-K filings have covered the announcement of a new share repurchase authorization of up to $750 million and the completion of a prior $150 million repurchase program, the release of quarterly financial results, the retirement of the president of Chamberlain University, and the adoption of a Rule 10b5-1 trading plan by the company’s chief executive officer. Another 8-K reports the results of Adtalem’s annual meeting of shareholders, including director elections, auditor ratification, and an advisory vote on executive compensation.
Investors can also review Forms 4 and related insider trading disclosures referenced in company communications, which report transactions executed under trading plans such as the disclosed Rule 10b5-1 plan. Together, these filings provide a regulatory record of Adtalem’s financial performance, capital allocation decisions, governance matters, and insider activity.
Stock Titan’s platform enhances these filings with AI-powered summaries that highlight key points from lengthy documents, making it easier to identify segment performance, capital allocation actions, and governance changes without reading every page. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 filings for ATGE are available promptly, while AI-generated explanations help readers interpret complex disclosures in accessible language.
Adtalem Global Education (ATGE) reported first-quarter fiscal 2026 results for the period ended September 30, 2025. Revenue rose to $462.3 million from $417.4 million, driven by Chamberlain $179.2 million, Walden $190.0 million, and Medical & Veterinary $93.1 million. Operating income increased to $85.5 million and net income to $61.8 million, with diluted EPS of $1.67 versus $1.18 a year ago.
Cash from operations was strong at $130.6 million, lifting cash and equivalents to $264.7 million. Interest expense declined to $11.1 million. The company repurchased 56,817 shares for $7.6 million in the quarter; $142.4 million remains authorized. Deferred revenue rose to $322.9 million, reflecting student billing cycles and material rights.
Adtalem ended the quarter with long-term debt principal of $558.3 million (Notes $405.0 million, Term Loan B $153.3 million) and subsequently prepaid $50.0 million on
Adtalem Global Education Inc. (ATGE) furnished an 8‑K announcing that it issued a press release with its first quarter fiscal 2026 academic, operating, and financial results. The press release is attached as Exhibit 99.1 and incorporated by reference.
The company states this information is provided under Item 2.02 and is furnished, not filed under the Exchange Act. The filing includes a customary caution about forward‑looking statements referencing risk factors in its most recent 10‑K.
Adtalem Global Education (ATGE) reported an insider transaction by its CHRO. On 10/15/2025, 1,310 shares of common stock were withheld at
Following this tax withholding, the reporting person beneficially owns 8,603 shares, held directly.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting beneficial ownership of 1,854,006 shares of Adtalem Global Education Inc. Common Stock, representing
The filing shows 1,802,111 shares with sole voting power and 1,854,006 shares with sole dispositive power. Dimensional certifies the securities are held in the ordinary course of business and not for the purpose of influencing control. The filing is signed by the Global Chief Compliance Officer on
Adtalem Global Education, Inc. reported a leadership change at Chamberlain University following the retirement of Dr. Cox after a distinguished, nearly 40-year career in healthcare and nursing education. Dr. Cox led Chamberlain since 2018, during which the institution expanded to serve nearly 40,000 students online and across 24 physical campuses and became the largest school of nursing in the U.S. and the leading grantor of Bachelor of Science in Nursing degrees. The filing frames this as a material event related to leadership transition; financial results, transactions, and other operational details were not disclosed in the provided excerpt.
Stephen W. Beard, Chairman & CEO of Adtalem Global Education Inc. (ATGE), reported a sale of common stock on 09/08/2025. The Form 4 shows 12,943 shares were disposed of at $136.28 per share, leaving Mr. Beard with 459,734 shares beneficially owned on a direct basis. The filing states the sale represented the satisfaction of tax withholding obligations upon the vesting of previously awarded restricted stock units. The form was signed by an attorney-in-fact on 09/09/2025.
Insider sale by Adtalem director Lisa Wardell: The filing shows that on 08/28/2025 Ms. Lisa Wardell, a director of Adtalem Global Education Inc. (ATGE), sold 25,477 shares of the company's common stock in multiple trades at prices ranging from $130.22 to $133.72. The form reports a weighted-average sales price of $132.3807. After the reported disposition, Ms. Wardell beneficially owned 43,451 shares, held directly. The Form 4 was signed by an attorney-in-fact, Lawrence C. Bachman, on 08/29/2025. The reporting checkbox indicates this filing was submitted by one reporting person and identifies Ms. Wardell as a director.
Adtalem Global Education (ATGE) Form 144 shows an insider intends to sell 25,477 common shares through Morgan Stanley Smith Barney with an aggregate market value of $3,372,663.09, listing the NYSE as the exchange and an approximate sale date of 08/28/2025. The filing discloses the shares were acquired via company compensation: restricted stock vesting and performance stock units between 08/25/2024 and 08/25/2025, totaling 25,477 shares. It also reports insider sales in the past three months: 18,392 shares on 08/27/2025 and 12,900 shares on 08/21/2025, generating gross proceeds of $2,486,889.00 and $1,714,465.47 respectively. The filer certifies no undisclosed material adverse information.
Insider transactions by a company director were disclosed. The reporting person, Lisa Wardell, identified as a director of Adtalem Global Education Inc. (ATGE), had previously vested restricted stock units that triggered a tax-withholding satisfaction of 5,157 shares, recorded as a disposition at a price of $135.33, leaving 87,320 shares beneficially owned after that action.
Subsequently, the reporting person sold 18,392 shares in multiple trades at a weighted-average price of $135.2158, reducing beneficial ownership to 68,928 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Insider transactions by Trent Evan at Adtalem Global Education (ATGE): The filing reports multiple issuances and withholdings of common stock tied to vested performance stock units and restricted stock units in late August 2025. On 08/23/2025 and 08/24/2025 Mr. Evan received a total of 17,664 shares issued as payouts of performance awards (9,312 and 8,352), with additional routine tax-withholding dispositions reducing his direct holdings. Share prices reported on transactions were $134.88 and $135.33. After the reported activity, beneficial ownership figures moved between 18,461 and 26,813 shares across the reported lines. The form is a routine Section 16 disclosure documenting award payouts and tax withholdings.
FAQ
What is the current stock price of Adtalem Global Ed (ATGE)?
What is the market cap of Adtalem Global Ed (ATGE)?
